Today, WellDoc® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar®, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes. The Providence Health & Services pilot program will include individuals living with type 2 diabetes and will evaluate the impact of a digital therapeutic—when used in conjunction with the support of a dedicated Diabetes Educator—on user engagement, retention, satisfaction and clinical outcomes.
{iframe}https://www.welldoc.com/images/uploads/WellDocs_Announcement_of_Providence_Pilot_Program_-_Press_Release_-_FINAL.docx_.pdf{/iframe}